Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GiSAS trial: aripiprazole, olanzapine and haloperidol in long-term treatment of schizophrenia
2007-000278-22Phase 4Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aripiprazole, olanzapine and haloperidol in schizophrenia (3 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoints: Onset of metabolic syndrome and Discontinuation of treatment for any reason. Started Apr 2007; status: completed.
02
Drugs
aripiprazoleolanzapinehaloperidol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-000278-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000278-22.